• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Postpartum hemophilia A with factor VIII inhibitor].

作者信息

Neidhardt B, Bartels O, Hahn B

出版信息

Dtsch Med Wochenschr. 1985 May 17;110(20):799-802. doi: 10.1055/s-2008-1068907.

DOI:10.1055/s-2008-1068907
PMID:3922727
Abstract

An abnormal life-threatening haemorrhagic diathesis occurred 6 weeks after delivery in a 25-year-old female. The reason was a spontaneously acquired factor VIIIC inhibitor haemophilia. The clinical presentation was characterised by extensive deep-seated soft-tissue haemorrhages of the extremities, a retroperitoneal haemorrhage, haematuria and recurrent joint bleedings. The activity of factor VIIIC decreased to below 1% of normal. The factor VIII inhibitor reached a maximum of 122 Bethesda units. The recurrent knee joint haemorrhages responded well to treatment with an activated prothrombin complex concentrate (Feiba). Repeated Feiba administration did not lead to an increase of the factor VIII inhibitor. It disappeared completely within 16 months and did not recur during a second pregnancy. The pregnancy was without complications and delivery on time resulted in a healthy child. Six months after the second pregnancy both mother and child showed no evidence of a disorder of haemostasis.

摘要

相似文献

1
[Postpartum hemophilia A with factor VIII inhibitor].
Dtsch Med Wochenschr. 1985 May 17;110(20):799-802. doi: 10.1055/s-2008-1068907.
2
[Acquired haemophilia A].[获得性血友病A]
Ned Tijdschr Geneeskd. 1997 Jul 5;141(27):1342-4.
3
[Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].产后肉眼血尿:一例妊娠后获得性血友病的罕见病例
G Ital Nefrol. 2002 Mar-Apr;19(2):204-8.
4
[Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].[重组活化凝血因子VII(诺和七,诺和诺德公司)用于获得性凝血因子VIII抑制物血友病的止血治疗]
Schweiz Med Wochenschr. 1995 Mar 4;125(9):405-11.
5
The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.活化凝血酶原复合物浓缩剂(FEIBA)对甲型血友病及抗凝血因子 VIII 抗体患者关节和肌肉出血的影响。一项双盲临床试验。
N Engl J Med. 1981 Sep 24;305(13):717-21. doi: 10.1056/NEJM198109243051301.
6
[Suppression of factor VIII inhibitor in children with hemophilia A].
Padiatr Padol. 1987;22(4):345-52.
7
[Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
Acta Haematol Pol. 1994;25(4):349-54.
8
[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].[通过定期输注凝血因子 VIII 在高反应性抑制物的甲型血友病患者中成功诱导免疫耐受及产生新型止血效果]
Rinsho Ketsueki. 1996 Nov;37(11):1303-8.
9
Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine.
Ann Pharmacother. 2004 Sep;38(9):1432-4. doi: 10.1345/aph.1E100. Epub 2004 Jul 20.
10
Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.严重产后获得性甲型血友病患者接受免疫抑制治疗后,高滴度的凝血因子VIII抑制剂迅速下降。
Croat Med J. 2004 Apr;45(2):213-6.